Skip to main content

. 1971 Oct 23;4(5781):212–213. doi: 10.1136/bmj.4.5781.212

Jakob-Creutzfeldt disease: treatment by amantadine.

PMCID: PMC1799277 PMID: 4940159

212

Images in this article

FIG. 1
on p.213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gibbs C. J., Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M., Matthews W. B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
JONES D. P., NEVIN S. Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 1954 May;17(2):148–159. doi: 10.1136/jnnp.17.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
Parkes J. D., Sharpstone P., Williams R. Levodopa in hepatic coma. Lancet. 1970 Dec 26;2(7687):1341–1343. doi: 10.1016/s0140-6736(70)92362-7. [DOI] [PubMed] [Google Scholar]
Schwab R. S., England A. C., Jr, Poskanzer D. C., Young R. R. Amantadine in the treatment of Parkinson's disease. JAMA. 1969 May 19;208(7):1168–1170. [PubMed] [Google Scholar]

ACTIONS

RESOURCES